Linical Co (TSE:2183) Other Current Liabilities: 円4,502 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2183 Linical Co Ltd TSE:2183
44 GF Score
Price 円208.00
GF Value 円318.83
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Linical Co Other Current Liabilities?

Linical Co TSE:2183 +0.97% 44 Other Current Liabilities is 円4,502 Mil as of Mar. 2026. GuruFocus rates TSE:2183 with a GF Score™ of 44/100 and a GF Value™ of 円318.83 (Possible Value Trap). The stock has 5 warning signs investors should review.

Linical Co's other current liabilities for the quarter that ended in Mar. 2026 was 円4,502 Mil.

Linical Co's quarterly other current liabilities declined from Mar. 2025 (円5,820 Mil) to Sep. 2025 (円4,621 Mil) and declined from Sep. 2025 (円4,621 Mil) to Mar. 2026 (円4,502 Mil).

Linical Co's annual other current liabilities increased from Mar. 2024 (円5,541 Mil) to Mar. 2025 (円5,820 Mil) but then declined from Mar. 2025 (円5,820 Mil) to Mar. 2026 (円4,502 Mil).

Linical Co Other Current Liabilities Related Terms

Linical Co Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Linical Co's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Linical Co Other Current Liabilities Chart

Linical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,571.89 4,618.21 5,540.94 5,820.42 4,502.00

Linical Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,540.94 5,772.09 5,820.42 4,620.95 4,502.00
TSE:2183
44GF Score
Linical Co Ltd TSE:2183
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Linical Co Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of 円4,502 Mil mean?
Linical Co (TSE:2183) has a Other Current Liabilities of 円4,502 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Linical Co.
Is Linical Co's Other Current Liabilities too high?
Linical Co's current Other Current Liabilities is 円4,502 Mil. Overall, Linical Co has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Linical Co's Other Current Liabilities compare to VRTX and REGN?
Linical Co's Other Current Liabilities of 円4,502 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Linical Co. Linical Co's current Other Current Liabilities is 円4,502 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Linical Co stock overvalued right now?
Based on GuruFocus' analysis, Linical Co (TSE:2183) is currently considered Possible Value Trap. The stock's GF Value™ is 円318.83, compared to a current price of 円208.00 — trading 34.8% below its estimated fair value. The current Other Current Liabilities is 円4,502 Mil. Linical Co's overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Linical Co (TSE:2183), the current Other Current Liabilities is 円4,502 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Linical Co (TSE:2183) Overvalued in 2026?

Based on GuruFocus' analysis, Linical Co stock appears to be undervalued. The current stock price of 円208.00 is trading 34.8% below its estimated GF Value™ of 円318.83. GuruFocus considers Linical Co to be Possible Value Trap.

Key valuation signals for TSE:2183:

  • Other Current Liabilities: 円4,502 Mil
  • GF Value™: 円318.83 vs. price of 円208.00 (34.8% below fair value)
  • GF Score™: 44/100 with 5 warning signs

No single metric tells the full story. See the TSE:2183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Linical Co Business Description

Address 1-6-1 Miyahara, 10th floor, Shin-Osaka Brick Building, Yodogawa-ku, Osaka, JPN, 532-0003
Linical Co Ltd is a pharmaceutical company.
44GF Score

Get the complete analysis for TSE:2183

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円208.00
Price
円318.83
GF Value